Early experience with defeye

Some corneas just won't close. Post-SK, recurrent erosions, persistent epithelial defects: the patients who've been through drops, lenses and cryopreserved amniotic membrane and still come back with a defect. At AAO 2026 in New Orleans, David Szynkarski, MD of Mann Eye Institute in Houston walked us through where BIOVANCE 3L Ocular, a decellularized basement membrane graft from DefEYE, has landed in his practice. Placed in the office, dried with a Weck-Cel, pressure patch for 24 to 48 hours, follow-up a week or two later. His read so far: it stays put on bare stroma, patients tolerate it well, and the hard-to-heal defects are closing